Revolution Medicines Overview
Revolution Medicines Target Price
Where could RVMD trade next? Consensus target price: $230.
Get informed when a big investor buys or sells
+ FollowShare Price
$205.89
Average Target Price
$232.78
13.1% upside
13.1% upside27 analysts in the last 4 months
High: $320 | Low: $175
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-24 | Goldman Sachs | $267 | 29.7% upside |  |
| 2026-09-10 | Morgan StanleySean Laaman | $255 | 23.9% upside | |
| 2026-09-09 | Stifel NicolausLaura Prendergast | $230 | 11.7% upside | |
| 2026-08-31 | Needham | $275 | 33.6% upside | |
| 2026-08-28 | Guggenheim | $275 | 33.6% upside | |
| 2026-08-28 | UBS | $265 | 28.7% upside | |
| 2026-08-27 | RBC CapitalLeonid Timashev | $251 | 21.9% upside | |
| 2026-08-27 | Evercore ISI | $320 | 55.4% upside | |
| 2026-08-27 | H.C. WainwrightRobert Burns | $280 | 36% upside | |
| 2026-08-27 | Raymond JamesSean McCutcheon | $248 | 20.5% upside | |
| 2026-08-26 | Oppenheimer | $260 | 26.3% upside | |
| 2026-08-21 | BernsteinJeffrey Walch | $179 |  13.1% downside | |
| 2026-08-11 | Truist Financial | $231 | 12.2% upside | |
| 2026-08-10 | Wolfe ResearchKalpit Patel | $220 | 6.9% upside | |
| 2026-08-06 | RBC Capital | $203 | 1.4% downside | |
| 2026-08-06 | Wedbush | $201 | 2.4% downside | |
| 2026-08-06 | Evercore ISI | $230 | 11.7% upside | |
| 2026-08-06 | Oppenheimer | $230 | 11.7% upside | |
| 2026-08-06 | GuggenheimMichael Schmidt | $240 | 16.6% upside | |
| 2026-07-23 | WedbushRobert Driscoll | $192.1 | 6.7% downside | |
| 2026-07-09 | GuggenheimMichael Schmidt | $235 | 14.1% upside | |
| 2026-07-06 | Mizuho Securities | $215 | 4.4% upside | |
| 2026-07-02 | Wedbush | $181 | 12.1% downside | |
| 2026-06-30 | Truist Financial | $210 | 2% upside | |
| 2026-06-29 | NeedhamAmi Fadia | $235 | 14.1% upside | |
| 2026-06-09 | UBSMichael Yee | $175 | 15% downside | |
| 2026-06-02 | RBC CapitalLeonid Timashev | $182 | 11.6% downside | |
| 2026-06-01 | H.C. Wainwright | $195 | 5.3% downside | |
| 2026-06-01 | Oppenheimer | $195 | 5.3% downside | |
| 2026-05-21 | BernsteinJeffrey Walch | $151 | 26.7% downside | |
| 2026-05-18 | Truist Financial | $179 | 13.1% downside | |
| 2026-05-07 | Guggenheim | $205 | 0.4% downside | |
| 2026-04-14 | RBC Capital | $162 | 21.3% downside | |
| 2026-04-14 | Guggenheim | $175 | 15% downside | |
| 2026-04-14 | Evercore ISI | $200 | 2.9% downside | |
| 2026-04-14 | H.C. WainwrightRobert Burns | $169 | 17.9% downside | |
| 2026-04-13 | Oppenheimer | $165 | 19.9% downside | |
| 2026-02-26 | Wells FargoEva Fortea Verdejo | $144 | 30.1% downside | |
| 2026-01-27 | OppenheimerJay Olson | $150 | 27.1% downside | |
| 2026-01-22 | UBS | $170 | 17.4% downside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $140 | 32% downside | |
| 2026-01-20 | Guggenheim | $160 | 22.3% downside | |
| 2026-01-13 | Goldman SachsAndrea Newkirk | $73 | 64.5% downside | |
| 2026-01-13 | Mizuho Securities | $143 | 30.5% downside | |
| 2026-01-09 | Wedbush | $147 | 28.6% downside | |
| 2025-11-03 | RBC CapitalLeonid Timashev | $77 | 62.6% downside | |
| 2025-10-17 | National BankAlex Stranahan | $80 | 61.1% downside | |
| 2025-10-17 | Raymond James | $76 | 63.1% downside | |
| 2025-10-15 | Stifel Nicolaus | $85 | 58.7% downside | |
| 2025-09-05 | Truist Financial | $99 | 51.9% downside | |